Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I think RG anticipates a higher share price.
Reply New Message
Prev Message Back To Forum Threaded View Next Message

We know that the added shares are an added liability. But what about accounting for the acquired entity (asset). How does that hit the books? Do we take an immediate paper loss to be (hopefully) regained over time?

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply